Why Hypothermia Is Lethal in Trauma Patients
Hypothermia (core temperature <35°C) is one leg of the trauma "lethal triad" (with acidosis and coagulopathy), and it acts as both a cause and an amplifier of the other two, creating a self-perpetuating "bloody vicious cycle" that drives mortality upward - the effect is dose-dependent: mortality has been reported around 20-50%+ once core temperature drops below 32-34°C, with essentially no survivors below 32°C in some trauma series (Sabiston Textbook of Surgery, p. 1220-1226; Rockwood and Green's Fractures in Adults, p. 3047).
1. It directly causes coagulopathy
- Hypothermia impairs coagulation not by increasing clot breakdown, but by impeding clot formation: it reduces the enzymatic activity of clotting factor proteases (a temperature-dependent process), so even with normal factor levels, clotting reactions slow dramatically. It also inhibits platelet function - reducing thromboxane A2 release and platelet adhesion/aggregation - without necessarily lowering platelet count (Roberts and Hedges' Clinical Procedures in Emergency Medicine, p. 2636; Mulholland and Greenfield's Surgery, p. 1563).
- This produces a coagulopathy that standard clotting factor replacement (FFP, cryoprecipitate) cannot fully correct - "clotting factor supplementation is not the answer to hypothermia-induced coagulopathy; rewarming is" (Sabiston Textbook of Surgery, p. 1254).
- Worsened coagulopathy means ongoing hemorrhage, which drives further hypoperfusion, further heat loss, and further coagulopathy - the vicious cycle.
2. It worsens metabolic acidosis
- Hemorrhagic shock forces a switch to anaerobic metabolism, producing lactic acidosis. Hypothermia further impairs cellular metabolic and enzymatic processes, blunting the body's ability to buffer and clear this acid load, so acidosis deepens (Fischer's Mastery of Surgery, p. 306-320).
- Acidosis in turn depresses myocardial contractility, blunts the heart's response to inotropes/catecholamines, and further impairs clotting enzyme function - compounding both the cardiovascular and coagulation problems.
3. Cardiovascular and other systemic effects
- Below ~33-34°C, hypothermia predisposes to bradyarrhythmias and ventricular fibrillation, and depresses cardiac output at a time when oxygen delivery is already compromised by blood loss.
- It abolishes the shivering thermogenic response (further worsened by anesthetic/neuromuscular blocking agents given during resuscitation), so the patient has no physiologic mechanism left to rewarm.
- Oxyhemoglobin dissociation shifts left, impairing oxygen unloading to already hypoperfused tissues.
4. Why trauma patients become hypothermic in the first place
Multiple compounding exposures: prehospital environmental exposure, cold IV/blood resuscitation fluids, cold emergency department/OR environments, open body cavities during surgery (evaporative heat loss), and anesthetic agents blocking compensatory heat generation (Sabiston Textbook of Surgery, p. 1222).
The net effect
Each element of the triad accelerates the other two: hemorrhage → hypothermia → coagulopathy → more hemorrhage → worse acidosis → myocardial depression → death. This is why modern damage control resuscitation/surgery explicitly targets truncating operations early and aggressively rewarming (warmed fluids/blood, warm blankets, minimizing cavity exposure time) before irreversible physiologic collapse, rather than trying to complete definitive repair in a cold, coagulopathic, acidotic patient (Rockwood and Green's Fractures in Adults, p. 3047; Current Surgical Therapy 14e, p. 2434).
Recent systematic review literature continues to support this framework and is examining better prediction models for post-traumatic hypothermia risk (Zhang et al., Injury, 2025, PMID 41240776) and updated coagulation management guidelines for multiply injured patients (Lier et al., Eur J Trauma Emerg Surg, 2025, PMID 40576680) - these are consistent with, not contradictory to, the textbook mechanism above.